SCHEMBL3133634

SCHEMBL3133634

COc1cc(-c2ccc(F)cc2)ccc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
ACLY P53396 1/20 0.52
CHEK1 O14757 1/20 0.51
KDM4E B2RXH2 4/20 0.49
APAF1 O14727 1/20 0.49
RECQL P46063 1/20 0.49
CASP6 P55212 1/20 0.49
CACNA1B Q00975 1/20 0.49
APBA1 Q02410 1/20 0.49
MCL1 Q07820 1/20 0.49
CASP8 Q14790 1/20 0.49
CD274 Q9NZQ7 1/20 0.48
ADRB1 P08588 1/20 0.48
ADRB3 P13945 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HPGD P15428 2/20 0.47
HTT P42858 1/20 0.47
ROCK2 O75116 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2770512 0.89 ALDH1A1 (0.67) ALDH1A1CHEK1KDM4EAPAF1RECQL
SCHEMBL11692501 0.87 CFD (0.56) ALDH1A1ACLYKDM4EAPAF1RECQL
SCHEMBL29788086 0.86 CHEK1 (0.60) ALDH1A1ACLYCHEK1KDM4EAPAF1
SCHEMBL504872 0.86 CHEK1 (0.60) ALDH1A1ACLYCHEK1KDM4EAPAF1
SCHEMBL17177740 0.86 ALDH1A1 (0.62) ALDH1A1CHEK1KDM4EAPAF1RECQL
SCHEMBL927338 0.86 ALDH1A1 (0.62) ALDH1A1ACLYKDM4ENPC1RAB9A
SCHEMBL30675620 0.86 ALDH1A1 (0.62) ALDH1A1ACLYKDM4ENPC1RAB9A
SCHEMBL3138697 0.85 ALDH1A1 (0.54) ALDH1A1CHEK1KDM4EAPAF1RECQL
SCHEMBL3138823 0.85 SLC6A4 (0.58) ALDH1A1ACLYCHEK1KDM4ENPC1
SCHEMBL8758518 0.85 ACLY (0.49) ALDH1A1ACLYKDM4EAPAF1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004221-A1 THIAZEPINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-01-07 US disclosed
EP-2119719-A1 THIAZEPINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004221-A1 THIAZEPINE DERIVATIVE HSD11B1, HSD17B1, HSD3B1 ALDH1A1 28/4885ACLY 1441/4885CHEK1 1983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.